کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
10899309 | 1084363 | 2016 | 9 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
64Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133+ cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
64Cu-ATSM[18F]-fluorodeoxyglucoseTTNIRTBRCA2WBCPSL18FDG6-TG6-thioguanineFANCGPBS5-FUCTSeFANCACSCROS - ROSNucleic Acid - اسید نوکلئیکBrdU - بروموداکسی اوریدینbromodeoxyuridine - برومودسوویریدینanalysis of variance - تحلیل واریانسANOVA - تحلیل واریانس Analysis of varianceDNA repair - ترمیم DNAPositron emission tomography - توموگرافی گسیل پوزیترونTitin - تیتینInternal radiotherapy - رادیوتراپی داخلیCancer stem-like cell - سلول بنیادی سرطانی5-fluorouracil - فلوروراسیل-۵، فلوئورواوراسیلPhotostimulated luminescence - لنزهای عکسبرداریPhosphate-buffered saline - محلول نمک فسفات با خاصیت بافریCu-ATSM - مس ATSMHypoxia - هیپوکسیPET - پتPemetrexed - پمترکسید، آلیمتاCathepsin E - کاتهپسین Ewhite blood cell - گلبول سفید خونReactive oxygen species - گونههای فعال اکسیژن
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
تحقیقات سرطان
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
64Cu-diacetyl-bis (N4-methylthiosemicarbazone) (64Cu-ATSM) is a potential theranostic agent targeting the over-reduced state under hypoxia within tumors. Recent clinical Cu-ATSM positron emission tomography studies have revealed a correlation between uptake and poor prognosis; however, the reason is unclear. Here, using a human colon carcinoma HT-29 model, we demonstrated that the intratumoral 64Cu-ATSM high-uptake regions exhibited malignant characteristics, such as upregulated DNA repair and elevated %CD133+ cancer stem-like cells. Based on this evidence, we developed a strategy to enhance the efficacy of 64Cu-ATSM internal radiotherapy (IRT) by inhibiting DNA repair with a nucleic acid (NA) antimetabolite. The results of the analyses showed upregulation of pathways related to DNA repair along with NA incorporation (bromodeoxyuridine uptake) and elevation of %CD133+ cells in 64Cu-ATSM high-uptake regions. In an in vivo64Cu-ATSM treatment study, co-administration of an NA antimetabolite and 64Cu-ATSM synergistically inhibited tumor growth, with little toxicity, and effectively reduced %CD133+ cells. 64Cu-ATSM therapy targeted malignant tumor regions with activated DNA repair and high concentrations of CD133+ cells in the HT-29 model. NA antimetabolite co-administration can be an effective approach to enhance the therapeutic effect of 64Cu-ATSM IRT.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Cancer Letters - Volume 376, Issue 1, 28 June 2016, Pages 74-82
Journal: Cancer Letters - Volume 376, Issue 1, 28 June 2016, Pages 74-82
نویسندگان
Yukie Yoshii, Takako Furukawa, Hiroki Matsumoto, Mitsuyoshi Yoshimoto, Yasushi Kiyono, Ming-Rong Zhang, Yasuhisa Fujibayashi, Tsuneo Saga,